FDA.reportPublic FDA data

DORAVIRINE Pharmacologic Class Indexing

Class set ID
d71a2eaa-3266-4209-ac73-d6864d324612
Version
1
Effective date
20190712
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use IDVYNSO safely and effectively. See full prescribing information for IDVYNSO. IDVYNSO ™ (doravirine and islatravir) tablets, for oral use Initial U.S. Approval: 2026Merck Sharp & Dohme LLC202604203
These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018Merck Sharp & Dohme LLC2025102923
These highlights do not include all the information needed to use PIFELTRO safely and effectively. See full prescribing information for PIFELTRO. PIFELTRO ® (doravirine) tablets, for oral use Initial U.S. Approval: 2018Merck Sharp & Dohme LLC2025102920
These highlights do not include all the information needed to use PIFELTRO safely and effectively. See full prescribing information for PIFELTRO. PIFELTRO ® (doravirine) tablets, for oral use Initial U.S. Approval: 2018A-S Medication Solutions202401023